GKK1-FatigueLactobacillus Plantarum GKK1 for Fatigue Recovery in Active Adults
Lactobacillus plantarum GKK1 Probiotic
+ Placebo
Prevention Study
Summary
Study start date: September 24, 2024
Actual date on which the first participant was enrolled.This study explores whether taking a probiotic supplement called Lactobacillus plantarum GKK1 can help reduce tiredness and improve recovery after intense exercise. The supplement, derived from fermented plants, is believed to have beneficial effects on gut health and inflammation, which might aid in managing fatigue. The focus is on healthy adults who regularly engage in physical activities. Understanding if this supplement can help in reducing muscle stress and improving recovery could be beneficial for individuals looking to enhance their exercise performance and recovery. Participants in this study will take the probiotic supplement daily for 28 days while continuing their usual diet and lifestyle but avoiding other supplements. The study uses a controlled exercise routine designed to cause fatigue, such as repetitive jumping movements, to test the supplement's effectiveness. Blood and urine samples will be collected to track changes in stress and muscle damage markers. Both physical tests and personal feedback on fatigue will be used to measure effectiveness. The study aims to see if those taking the probiotic show fewer signs of stress and muscle damage compared to those who do not.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.48 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 35 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location